Key facts
- 52-week range (closes)
- $218.58 – $326.46 Lowest close Jun 29, 2026, highest Mar 2, 2026; 251 daily closes to Oct 13, 2026 from Dalsna Finance's price archive
- Fiscal year ends
- December Fiscal 2025 ended Dec 31, 2025, from SEC filings
- In the S&P 500 since
- Aug 11, 2006 · All S&P 500 changes
CME Group (CME) is trading up at $295.31 (+0.61%) on NYSE/NASDAQ, as of the latest quote. It is a S&P 500 constituent in the Financials sector.
CME Group revenue & net income history (FY2016–FY2025)
| FY2016Dec 2016 | FY2017Dec 2017 | FY2018Dec 2018 | FY2019Dec 2019 | FY2020Dec 2020 | FY2021Dec 2021 | FY2022Dec 2022 | FY2023Dec 2023 | FY2024Dec 2024 | FY2025Dec 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $3.60B | $3.64B | $4.31B | $4.87B | $4.88B | $4.69B | $5.02B | $5.58B | $6.13B | $6.52B |
| Growth (year over year) | +8.1% | +1.4% | +18.2% | +13.0% | +0.3% | −4.0% | +7.0% | +11.1% | +9.9% | +6.4% |
| Operating income | $2.20B | $2.31B | $2.61B | $2.59B | $2.64B | $2.65B | $3.02B | $3.44B | $3.93B | $4.23B |
| Operating margin | 61.2% | 63.4% | 60.5% | 53.2% | 54.0% | 56.4% | 60.1% | 61.6% | 64.1% | 64.9% |
| Net income | $1.53B | $4.06B | $1.96B | $2.12B | $2.11B | $2.64B | $2.69B | $3.23B | $3.53B | $4.07B |
| Net margin | 42.7% | 111.5% | 45.5% | 43.5% | 43.1% | 56.2% | 53.6% | 57.8% | 57.5% | 62.5% |
| EPS (diluted) | $4.53 | $11.94 | $5.71 | $5.91 | $5.87 | $7.29 | $7.40 | $8.86 | $9.67 | $11.16 |
| Balance sheet | ||||||||||
| Cash and equivalents | $1.87B | $1.90B | $1.37B | $1.55B | $1.63B | $2.83B | $2.72B | $2.91B | $2.89B | $4.42B |
| Total assets | $69.4B | $75.8B | $77.5B | $75.2B | $124.7B | $196.8B | $174.2B | $129.7B | $137.4B | $198.4B |
| Total liabilities | $49.0B | $53.4B | $51.5B | $49.1B | $98.3B | $169.4B | $147.3B | $103.0B | $111.0B | $169.7B |
| Shareholders' equity | $20.3B | $22.4B | $26.0B | $26.2B | $26.4B | $27.4B | $26.9B | $26.7B | $26.5B | $28.7B |
| Cash flow | ||||||||||
| Operating cash flow | $1.73B | $1.75B | $2.44B | $2.67B | $2.72B | $2.40B | $3.06B | $3.45B | $3.69B | $4.28B |
| Capital expenditure | $91.8M | $81.9M | $116.7M | $245.6M | $197.5M | $127.2M | $89.7M | $76.4M | $94.0M | $83.5M |
| Free cash flow | $1.64B | $1.67B | $2.32B | $2.43B | $2.52B | $2.28B | $2.97B | $3.38B | $3.60B | $4.19B |
| Dividends paid | $1.79B | $1.99B | $2.15B | $1.70B | $2.11B | $2.19B | $2.63B | $3.24B | $3.58B | $3.93B |
| Q3 FY24Sep 2024 | Q4 FY24†Dec 2024 | Q1 FY25Mar 2025 | Q2 FY25Jun 2025 | Q3 FY25Sep 2025 | Q4 FY25†Dec 2025 | Q1 FY26Mar 2026 | Q2 FY26Jun 2026 | |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $1.58B | $1.53B | $1.64B | $1.69B | $1.54B | $1.65B | $1.88B | $1.71B |
| Growth (year over year) | +18.4% | +6.0% | +10.4% | +10.4% | −3.0% | +8.1% | +14.5% | +0.8% |
| Operating income | $1.02B | $947.1M | $1.11B | $1.13B | $972.6M | $1.02B | $1.31B | $1.11B |
| Operating margin | 64.6% | 62.1% | 67.5% | 66.7% | 63.3% | 61.8% | 69.7% | 64.9% |
| Net income | $901.3M | $908.0M | $944.2M | $1.03B | $896.6M | $1.21B | $1.17B | $1.04B |
| Net margin | 56.9% | 59.5% | 57.5% | 60.6% | 58.3% | 73.2% | 62.1% | 61.1% |
| EPS (diluted) | $2.50 | $2.40 | $2.62 | $2.81 | $2.49 | $3.24 | $3.18 | $2.88 |
| Balance sheet | ||||||||
| Cash and equivalents | $2.32B | $2.89B | $1.41B | $1.98B | $2.45B | $4.42B | $2.39B | $2.14B |
| Total assets | $137.8B | $137.4B | $157.8B | $179.9B | $187.1B | $198.4B | $202.0B | $194.7B |
| Total liabilities | $109.6B | $111.0B | $130.8B | $152.2B | $159.0B | $169.7B | $175.4B | $168.2B |
| Shareholders' equity | $28.2B | $26.5B | $27.0B | $27.7B | $28.2B | $28.7B | $26.6B | $26.5B |
| Cash flow | ||||||||
| Operating cash flow | $1.00B | $1.02B | $1.12B | $1.06B | $968.1M | $1.13B | $1.26B | $947.1M |
| Capital expenditure | $29.8M | $26.2M | $14.2M | $18.4M | $18.4M | $32.5M | $21.8M | $23.6M |
| Free cash flow | $973.2M | $991.7M | $1.10B | $1.04B | $949.7M | $1.10B | $1.24B | $923.5M |
| Dividends paid | $418.5M | $418.8M | $2.57B | $455.3M | $455.3M | $455.0M | $2.70B | $468.1M |
From CME Group's 10-K and 10-Q filings with the SEC; its fiscal year ends in December. Each period shows the latest figure the company has reported for it, including restatements. Net margin is our own calculation from those reported figures (net income ÷ revenue); it is left blank where revenue is zero or missing. † Quarter derived from the company's year-to-date or full-year totals. Filings on SEC EDGAR →
CME Group vs the Financials sector and the S&P 500
CME Group's latest reported figures next to the median of the other 75 S&P 500 Financials companies and of the other 502 S&P 500 companies; each median is taken over the companies with a comparable figure (counts in the footnote). A median is the middle value, not an average, so one very large company does not move it.
| Measure | CME Group | Financials (75 other S&P 500 companies) | S&P 500 (502 other companies) |
|---|---|---|---|
| Revenue growth, latest fiscal year | +6.4% | +7.2% | +7.0% |
| Net margin, latest fiscal year | 62.5% | 19.3% | 12.9% |
| Dividend per share, latest fiscal year | $5.00 | $2.35 | $2.40 |
| Share price change, 1 year | +9.7% | +5.0% | +5.6% |
CME Group: fiscal year ended December 2025, from its 10-K and 10-Q filings with the SEC. Medians computed October 20, 2026 from each company's latest annual filing (fiscal years ending between July 2025 and September 2026) and our price archive. Prices for every company, CME Group included, are the last regular-session prices of October 19, 2026; the 1-year change compares that price with each company's last close on or before October 20, 2025. Net margin and price change are our calculations from reported figures. Each median counts only the companies with a comparable figure (sector / S&P 500): revenue growth 75/496, net margin 75/496, dividend per share 61/349, 1-year price change 75/490; the reasons below can overlap. 12 are left out of the price figure because our archive holds no comparable close for them; dividend medians are among the 61 sector and 349 S&P 500 companies reporting a per-share dividend. The S&P 500 price figure is the middle company's change, not the index's return.
About CME Group
CME Group Inc., headquartered in Chicago, Illinois, operates exchanges and provides clearing services for trading in financial derivatives such as futures contracts, options, and swaps. Its exchanges include the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX), and the Commodity Exchange (COMEX). The company also owns 27% of S&P Dow Jones Indices. The company operates the Globex Trading System, an electronic trading platform that allows customers in approximately 150 countries to trade futures and options contracts. The company also operates two platforms for spot market trading: BrokerTec, which facilitates dealer-to-dealer trading in fixed-income products, and EBS, which provides spot trading in foreign exchange markets. CME Clearing serves as a counterparty to every transaction cleared by the company.
- Headquarters
- Chicago, Illinois From SEC filings, Oct 2026
Recent News (2)
-
U.S. CFTC rebuffs CME legal stance in consequential fight over perpetual futures The future of perps in the U.S. may be at stake as the CFTC argues that CME hasn't shown the new policy is hurting it after the agency OK'd its first bitcoin perp.
-
More Financials stocks
- CB Chubb Limited
- CBOE Cboe Global Markets
- CFG Citizens Financial Group
- CINF Cincinnati Financial
- COF Capital One
- COIN Coinbase
- CPAY Corpay
- EG Everest Group